Cypress Capital Management LLC (Wy) Syndax Pharmaceuticals Inc Transaction History

Cypress Capital Management LLC (Wy)

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 09, 2022	SELL	$14.84 - $22.15 $74 - $110	-5 Closed	0 $0
Q3 2021 Nov 04, 2021	SELL	$13.87 - $19.8 $1,054 - $1,504	-76 Reduced 93.83%	5 $0
Q1 2021 May 07, 2021	SELL	$19.28 - $24.59 $990,008 - $1.26 Million	-51,349 Reduced 99.84%	81 $2,000
Q4 2020 Jan 29, 2021	BUY	$15.1 - $26.44 $776,593 - $1.36 Million	51,430 New	51,430 $1.14 Million

228

88.4M

1.01M

692K

Ticker SNDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,565,200
Market Cap $739M
Description
Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin...

Get notified when there are updates to the investment portfolio of Cypress Capital Management LLC (Wy), based on Form 13F filings with the SEC.

Stay updated on Cypress Capital Management LLC (Wy) with notifications on news.